The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.20
Bid: 21.20
Ask: 21.55
Change: 0.00 (0.00%)
Spread: 0.35 (1.651%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 21.20
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

H1 Trading Update and Contract Wins

9 Jan 2012 07:00

RNS Number : 1849V
Allocate Software PLC
09 January 2012
 



 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

First Half Year Trading Update and Contract Wins

 

Allocate Software plc (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, reports the following update for the six months ended 30 November 2011.

 

Summary

 

Allocate's performance in the first half year is in line with management's expectations for the period. The pipeline of business in the UK Healthcare sector is robust and continues at recent levels with Time Care in Sweden performing well and the Australian healthcare business continuing to develop. The performance of the Defence sector is also meeting expectations.

 

Healthcare

 

Key highlights include two important acquisitions in the period: RosterOn in Australia in July and Zircadian in the UK in August.

 

Allocate was awarded 12 new contracts for HealthRoster, the e-Rostering application, of which 11 were for the NHS, increasing the total NHS e-Rostering customer base to 156 Trusts. In addition, the company won:

 

§ 1 new HealthRoster win in Malaysia / Brunei

§ 3 NHS Trusts extended their HealthRoster licences

§ 4 new customer wins for Dynamic Change

§ 6 new customer wins for Time Care

 

Defence and other markets

 

§ Post half year end, the Defence business secured a major contract with the Australian Defence Force. The agreement is a multi-year, multimillion pound license extension to its current license base that will extend the deployment of MAPS to all personnel in the Australian Army.

§ The Maritime business closed an important new order with McDermott, the leading engineering, offshore oil and gas company.

 

 

Ian Bowles, Chief Executive Officer of Allocate commented on the period:

 

"I am pleased with the momentum and performance of Allocate in this half year. We are experiencing great customer support; in addition prospective customers are selecting our applications following competitive tendering processes, to support their own business objectives. We continue to see levels of opportunities consistent with recent periods with which we are engaging. Ideally, I would prefer to see a faster closure rate on some of the NHS transactions but I am reassured by the number of prospects that are coming to market and that NHS Trusts are increasingly engaging with us to discuss their plans.

 

"The integration of both the Zircadian and RosterOn businesses is making good progress.

 

"Our overseas territories have performed well in this period. The Australian operation has benefitted from the RosterOn acquisition bringing some 17 new staff as well as its own business and customers. Time Care again reported another period of consistent trading and growth and we are pleased that our Malaysian team has won another HealthRoster contract, our first national agreement that will see HealthRoster deployed across all public hospitals in Brunei.

 

"In Defence, we are delighted to have closed a major contract extension with the Australian Defence Force ('ADF'). This contract was concluded just after half year end so will be reflected in the second half financials. It extends further the deployment of MAPS in the Australian Army to now join Navy in addressing 100% of its total requirement for MAPS licences and also provides for a substantial number of Civilian staff associated with ADF.

 

"Despite the current environment, I am confident that we remain on track for our full year revenue and profit targets."

 

The Company's results for the half year to 30 November will be released in early February 2012.

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

Martin Jeffries - Marketing Director

 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Michael Meade / Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James

John Bick

Tel :+44 (0) 20 7193 7463

+44 (0) 7525 324 431

 

 

About Allocate Software plc

Allocate Software is the leading workforce and corporate governance software solutions provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include Healthcare and Defence.

 

The experience and in-depth knowledge, gained in the UK and internationally has enabled Allocate to invest in developing innovative solutions that are relevant to the constantly evolving market needs of its customers. At the core of the business is Allocate's workforce optimisation software, which streamlines the whole workforce management of multi disciplinary groups, across diverse locations.

 

Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

 

Allocate is quoted on the London Stock Exchange (AIM: ALL).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKFDQNBKBPDK
Date   Source Headline
2nd May 20247:00 amRNSApproval to List on the Ghana Stock Exchange
24th Apr 20247:00 amRNSQuarterly Activities and Cash Flow Report
18th Apr 20247:00 amRNSExploration-focused Investor Webinar
16th Apr 20247:00 amRNSInvestor Presentation - Paydirt Battery Minerals
8th Apr 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFurther Broad and High-Grade Drill Intersections
15th Mar 20247:00 amRNSHalf-year Financial Report
27th Feb 20247:00 amRNSConference Attendance
15th Feb 20247:00 amRNSDirector/PDMR Dealings
5th Feb 20247:00 amRNSMultiple Broad and High-Grade Drill Intersections
2nd Feb 20247:00 amRNSConference Attendance – Mining Indaba
1st Feb 20248:20 amRNSInvestor Presentation - Investor Webinar
31st Jan 20247:00 amRNSQuarterly Activities and Cash Flow Report
29th Jan 20247:00 amRNSInvestor Webinar
25th Jan 20247:00 amRNSUpdate on Competitive Offtake Partnering Process
24th Jan 20247:00 amRNSCompletion of US$5m MIIF Subscription
23rd Jan 20247:00 amRNSTR-1 Notification of Major Holdings
2nd Jan 20247:00 amRNSCorporate Update - Director / PDMR Shareholding
29th Dec 20237:00 amRNSCorporate Update - Director / PDMR Shareholding
28th Dec 20237:00 amRNSGrant of PDMR Performance Rights
22nd Dec 20237:00 amRNSDirector / PDMR Dealings & Shareholding Update
21st Dec 20237:00 amRNSCorporate Update - Director / PDMR Dealings
20th Dec 20237:00 amRNSBoard Changes
15th Dec 20237:00 amRNSSuccessful Completion of A$8million Equity Placing
14th Dec 20234:45 pmRNSA$7 million Equity Placing
12th Dec 20237:00 amRNSMaiden Feldspar Mineral Resource Estimate
30th Nov 202311:57 amRNSAmended Constitution
30th Nov 202311:50 amRNSResult of Annual General Meeting
30th Nov 20237:02 amRNSAGM Statement
28th Nov 20237:00 amRNS106m Continuous Pegmatite Interval Reported
23rd Nov 20239:39 amRNSUpdated Quarterly Activities and Cash Flow Report
22nd Nov 20237:00 amRNSProject Development Update
16th Nov 20237:00 amRNSInvestor Presentation - Noosa Mining Conference
15th Nov 20237:00 amRNSRejection of Non-Binding Indicative Offers
14th Nov 20237:00 amRNSGrant of Highly Prospective Licences for Lithium
10th Nov 20237:00 amRNSConference Attendance
7th Nov 20237:00 amRNSAdditional Resource Extension Drilling Planned
1st Nov 20237:00 amRNSChange of Registered Office
31st Oct 20237:05 amRNSNotice of AGM
31st Oct 20237:00 amRNSQuarterly Activities and Cash Flow Report
20th Oct 20237:00 amRNSMining Lease Granted for Ewoyaa Lithium Project
19th Oct 202311:35 amRNSStatement re Media Speculation
13th Oct 20237:00 amRNSConference Attendance
10th Oct 20237:00 amRNSApproval to Divert Transmission Lines at Ewoyaa
29th Sep 20239:55 amRNSInvestor Presentation
28th Sep 20237:00 amRNS2023 Annual Financial Report
21st Sep 20237:00 amRNSNotice of Results and Investor Presentation
15th Sep 20237:00 amRNSConference Attendance
8th Sep 20237:05 amRNSInvestor Presentation
8th Sep 20237:00 amRNSUS$32.9m Strategic Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.